SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001477932-23-004877
Filing Date
2023-06-28
Accepted
2023-06-28 17:00:09
Documents
6
Period of Report
2023-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K betrf_6k.htm 6-K 11455
2 MANAGEMENTS DISCUSSION AND ANALYSIS betrf_ex991.htm EX-99.1 169022
3 FINANCIAL STATEMENTS betrf_ex992.htm EX-99.2 537613
4 CEO CERTIFICATION betrf_ex993.htm EX-99.3 8963
5 CEO CERTIFICATION betrf_ex994.htm EX-99.4 8080
6 betrf_ex991img1.jpg GRAPHIC 4272
  Complete submission text file 0001477932-23-004877.txt   742335
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 438-884-8841
BetterLife Pharma Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 333-161157 | Film No.: 231052994
SIC: 2834 Pharmaceutical Preparations